Literature DB >> 22934790

Inhibitory effects of SA4503 on the rewarding effects of abused drugs.

Tomohisa Mori1, Mahardian Rahmadi, Kazumi Yoshizawa, Toshimasa Itoh, Masahiro Shibasaki, Tsutomu Suzuki.   

Abstract

Previous findings have shown that sigma-1 receptors (Sig-1Rs) are upregulated by the self-administration of methamphetamine, whereas Sig-1R antisense can attenuate the behavioral effects of psychostimulants in rodents. Sig-1R is an endoplasmic reticulum chaperone protein. However, the effects of Sig-1R agonist on the rewarding effects of abused drugs are not fully understood. Therefore, we examined the effects of selective Sig-1R agonists, such as SA4503 and (+)-pentazocine, on the rewarding effects of abused drugs such as methamphetamine, cocaine and morphine in rats, as measured by the conditioned place preference. Methamphetamine, cocaine and morphine induced a significant place preference. SA4503, but not (+)-pentazocine, significantly attenuated the abused drug-induced place preference. We recently showed that (+)-pentazocine exerts U50,488H-like discriminative stimulus effects, which are related to its psychotomimetic/aversive effects. However, SA4503 did not generalize to the discriminative stimulus effects of U50,488H. These results suggest that SA4503 inhibits the rewarding effects of abused drugs, and that psychotomimetic/aversive effects may not play a role in the attenuating effects of SA4503 on the rewarding effects of abused drugs.
© 2012 The Authors, Addiction Biology © 2012 Society for the Study of Addiction.

Entities:  

Keywords:  Abused drugs; SA4503; sigma-1 receptor

Mesh:

Substances:

Year:  2012        PMID: 22934790     DOI: 10.1111/j.1369-1600.2012.00488.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  10 in total

Review 1.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

2.  N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice.

Authors:  Dennis K Miller; Eric S Park; Susan Z Lever; John R Lever
Journal:  Pharmacol Biochem Behav       Date:  2016-11-13       Impact factor: 3.533

3.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

Review 4.  A role for sigma receptors in stimulant self-administration and addiction.

Authors:  Jonathan L Katz; Weimin C Hong; Takato Hiranita; Tsung-Ping Su
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

5.  The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice.

Authors:  Melissa A Tapia; Andrew S Sage; Emma I Fullerton; Jessica M Judd; Paige C Hildebrant; Matthew J Will; Susan Z Lever; John R Lever; Dennis K Miller
Journal:  Psychopharmacology (Berl)       Date:  2019-12-10       Impact factor: 4.530

Review 6.  Sigma Receptors and Substance Use Disorders.

Authors:  Valentina Sabino; Callum Hicks; Pietro Cottone
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 3.650

7.  Effects of the GluN2B-selective antagonist Ro 63-1908 on acquisition and expression of methamphetamine conditioned place preference in male and female rats.

Authors:  Justin R Yates; Hunter L Campbell; Lauren L Hawley; Matthew J Horchar; Joy L Kappesser; Makayla R Wright
Journal:  Drug Alcohol Depend       Date:  2021-05-26       Impact factor: 4.852

8.  The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.

Authors:  Danielle O Sambo; Min Lin; Anthony Owens; Joseph J Lebowitz; Ben Richardson; Darin A Jagnarine; Madhur Shetty; Meghan Rodriquez; Taiwo Alonge; Mishaal Ali; Jonathan Katz; Long Yan; Marcelo Febo; L Keith Henry; Adriaan W Bruijnzeel; Lynette Daws; Habibeh Khoshbouei
Journal:  Nat Commun       Date:  2017-12-20       Impact factor: 14.919

9.  N-Phenylpropyl-N'-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice.

Authors:  Andrew S Sage; Scott C Vannest; Kuo-Hsien Fan; Matthew J Will; Susan Z Lever; John R Lever; Dennis K Miller
Journal:  ISRN Pharmacol       Date:  2013-09-05

10.  Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function.

Authors:  Chowdhury S Abdullah; Richa Aishwarya; Shafiul Alam; Mahboob Morshed; Naznin Sultana Remex; Sadia Nitu; Gopi K Kolluru; James Traylor; Sumitra Miriyala; Manikandan Panchatcharam; Brandon Hartman; Judy King; Mohammad Alfrad Nobel Bhuiyan; Sunitha Chandran; Matthew D Woolard; Xiuping Yu; Nicholas E Goeders; Paari Dominic; Connie L Arnold; Karen Stokes; Christopher G Kevil; A Wayne Orr; Md Shenuarin Bhuiyan
Journal:  Commun Biol       Date:  2020-11-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.